N-[11C]-methyl-hydroxyfasudil is a potential biomarker of cardiac hypertrophy
Steven Moreau(University of Ottawa), Ana C. Valdivia(University of Ottawa), Jean N. DaSilva(Centre Hospitalier de l’Université de Montréal)
Cited by 4
Related Papers
The Use of <sup>18</sup>F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience
|Journal of Nuclear Medicine|2012|512
<sup>18</sup>F-FDG PET Imaging of Myocardial Viability in an Experienced Center with Access to <sup>18</sup>F-FDG and Integration with Clinical Management Teams: The Ottawa-FIVE Substudy of the PARR 2 Trial
|Journal of Nuclear Medicine|2010|154
The role of F18-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis
|Journal of Nuclear Cardiology|2013|87
Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging–Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease
|Circulation Cardiovascular Imaging|2016|86
The Effects of Continuous Positive Airway Pressure on Myocardial Energetics in Patients With Heart Failure and Obstructive Sleep Apnea
|Journal of the American College of Cardiology|2007|75